Amazon Pharmacy Adds Zepbound KwikPen at $299 Monthly, Expands Same-Day Delivery
Amazon Pharmacy will begin offering Eli Lilly’s Zepbound KwikPen for multi-dose tirzepatide therapy at transparent cash pricing starting at $299 per month for the 2.5 mg dose. Same-day delivery now covers over 50% of U.S. households, with plans to expand to nearly 4,500 cities and towns by end of 2026.
1. Device Offering and Pricing
Amazon Pharmacy has added Zepbound KwikPen, a multi-dose tirzepatide device designed to deliver a full month’s medication in a single pen. Pricing starts at $299 per month for the 2.5 mg starter dose under a transparent cash-pay model.
2. Distribution and Delivery Expansion
Amazon Pharmacy currently offers same-day delivery to more than half of U.S. households and intends to expand service to nearly 4,500 cities and towns by end of 2026 to increase patient access to obesity therapies.
3. Competitive GLP-1 Landscape
This move places Amazon Pharmacy deeper into the fast-growing GLP-1 market, competing with telehealth partnerships like Novo Nordisk’s Wegovy distribution via Hims & Hers and other digital health providers.
4. Strategic Implications for Amazon
By integrating weight-management therapies into its platform, Amazon enhances its broader healthcare ecosystem, potentially boosting pharmacy revenue and subscription engagement as GLP-1 demand accelerates.